Tags Archives: argatroban

thumbnail
0 comment

Argatroban in Patients with Extracorporeal Membrane Oxygenation—A Randomized Controlled Pilot Trial

Abstract INTRODUCTION Unfractionated heparin (UFH) is the most commonly used anticoagulant during extracorporeal membrane oxygenation (ECMO) (1). However, UFH also has several limitations: (i) it requires individualized dosing and close..

Read More
thumbnail
0 comment

Use of the CytoSorb® filter for elimination of residual therapeutic argatroban concentrations during heparinized cardiopulmonary bypass for heart transplantation

This case reports on a 34-year-old male patient with a medical history of corrected Fallot tetralogy, who was scheduled for heart transplantation. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/06/CoW_25_2022_E_web_compressed.pdf"]

Read More
thumbnail
0 comment

Hemostatic Management in Extracorporeal Membrane Oxygenation

Abstract The use of extracorporeal membrane oxygenation (ECMO) for acute cardiac and/or respiratory failure has grown exponentially in the past several decades. Systemic anticoagulation is a fundamental element of caring..

Read More
thumbnail
0 comment

Argatroban for Anticoagulation in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019

Abstract OBJECTIVES: A significant proportion of patients with coronavirus disease 2019 requiring venovenous extracorporeal membrane oxygenation at our institution demonstrated heparin resistance, which in combination with a heparin shortage resulted..

Read More